2008
DOI: 10.4161/pri.2.4.7773
|View full text |Cite
|
Sign up to set email alerts
|

Intracellular trafficking and dynamics of P bodies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
24
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 33 publications
(29 citation statements)
references
References 37 publications
3
24
0
Order By: Relevance
“…21,22 AG nucleation relies on the expression of the active tyrosine kinase part of the ALK protein and is abolished when ALK + cells are treated with an ALK specific inhibitor. 24 Akin to PBs and with similar kinetics, 5 AGs move along microtubules where they frequently contact PBs ( fig. 1 and reviewed in ref.…”
Section: S Fraction From Alkmentioning
confidence: 90%
See 3 more Smart Citations
“…21,22 AG nucleation relies on the expression of the active tyrosine kinase part of the ALK protein and is abolished when ALK + cells are treated with an ALK specific inhibitor. 24 Akin to PBs and with similar kinetics, 5 AGs move along microtubules where they frequently contact PBs ( fig. 1 and reviewed in ref.…”
Section: S Fraction From Alkmentioning
confidence: 90%
“…Photo-bleaching experiments confirmed that some components are indeed rapidly exchanged between RNA granules and the cytoplasm while others are almost static. [5][6][7] PBs, and to a lesser extent SGs, are highly dynamic entities that use the cytoskeleton to move, assemble and disassemble. 5,8 During their movements, PBs may come into close contact and frequently fuse with each other.…”
Section: Mammalian Pbs and Sgsmentioning
confidence: 99%
See 2 more Smart Citations
“…Initially identified through the use of an autoimmune serum targeting a glycine-tryptophan-rich protein, GW182, these membranefree structures are also called GW bodies (Eystathioy et al 2002). They are anchored to microtubules and move around in the cytoplasm (Aizer and Shav-Tal 2008;Lindsay and McCaffrey 2011). mRNA decay intermediates are found in P-bodies, and inhibition of 59-to-39 mRNA decay increases the size of P-bodies (Sheth and Parker 2003), suggesting that mRNAs can be degraded in P-bodies.…”
Section: Introductionmentioning
confidence: 99%